CLINICAL CHARACTERISTICS OF IMPORTED MALARIA IN JAPAN: ANALYSIS AT A REFERRAL HOSPITAL

TOSHIYUKI MIURA Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by TOSHIYUKI MIURA in
Current site
Google Scholar
PubMed
Close
,
MIKIO KIMURA Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by MIKIO KIMURA in
Current site
Google Scholar
PubMed
Close
,
TOMOHIKO KOIBUCHI Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by TOMOHIKO KOIBUCHI in
Current site
Google Scholar
PubMed
Close
,
TOKIOMI ENDO Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by TOKIOMI ENDO in
Current site
Google Scholar
PubMed
Close
,
HITOMI NAKAMURA Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by HITOMI NAKAMURA in
Current site
Google Scholar
PubMed
Close
,
TAKASHI ODAWARA Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by TAKASHI ODAWARA in
Current site
Google Scholar
PubMed
Close
,
YUSUKE WATAYA Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by YUSUKE WATAYA in
Current site
Google Scholar
PubMed
Close
,
TETSUYA NAKAMURA Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by TETSUYA NAKAMURA in
Current site
Google Scholar
PubMed
Close
, and
AIKICHI IWAMOTO Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan

Search for other papers by AIKICHI IWAMOTO in
Current site
Google Scholar
PubMed
Close
Restricted access

Imported malaria remains an important problem in Japan. We have reviewed the medical records of 170 cases of malaria in our hospital, which corresponds to 14.9% of the total cases in Japan. The predominant malarial species was Plasmodium falciparum (52.3%), and the most frequent area of acquisition was Africa (54.2%), followed by Asia (20.9%) and Oceania (19.6%). The most common reason for travel among Japanese patients was business. A significant proportion (22.2%) of vivax malaria cases experienced relapse despite standard primaquine therapy. Most primaquine failures were from Oceania. We also found that a substantial number of Japanese patients contracted malaria without chemoprophylaxis and consulted medical facilities with an unfavorably long delay from initial symptoms (median: 3.0 days). Direct education of travelers and travel companies, in addition to health care providers, is likely necessary to improve outcomes of imported malaria.

Author Notes

Reprint requests: Tetsuya Nakamura, Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan, Telephone: +81-3-5449-5338, Fax: +81-3-5449-5427, E-mail: tnakamur@ims.u-tokyo.ac.jp.
  • 1

    Kano S, Kimura M, 2004. Trends in malaria cases in Japan. Acta Trop 89 :271–278.

  • 2

    Kimura M, Suzaki A, Matsumoto Y, Nakajima K, Wataya Y, Ohtomo H, 2003. Epidemiological and clinical aspects of malaria in Japan. J Travel Med 10 :122–127.

  • 3

    Ohtomo H, Takeutchi T, 1998. Studies on current trend of imported malaria in Japan. Jpn J Trop Med Hyg 26 :151–156.

  • 4

    Kimura M, Miyake H, Kim HS, Tanabe M, Arai M, Kawai S, Yamane A, Wataya Y, 1995. Species-specific PCR detection of malaria parasites by microtiter plate hybridization: clinical study with malaria patients. J Clin Microbiol 33 :2342–2346.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Muentener P, Schlagenhauf P, Steffen R, 1999. Imported malaria (1985–95): trends and perspectives. Bull World Health Organ 77 :560–566.

  • 6

    Bradley DJ, Warhurst DC, Blaze M, Smith V, Williams J, 1998. Malaria imported into the United Kingdom in 1996. Euro Surveill 3 :40–42.

  • 7

    Apitzsch L, Rasch G, Kiehl W, 1998. Imported malaria in Germany in 1996. Euro Surveill 3 :35–36.

  • 8

    Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ, 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337 :1140–1143.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Smithuis FM, van Woensel JB, Nordlander E, Vantha WS, ter Kuile FO, 1993. Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob Agents Chemother 37 :1977–1981.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JP, Bisoffi Z, Matteelli A, Clerinx J, Corachan M, Puente S, Gjorup I, Harms G, Kollaritsch H, Kotlowski A, Bjorkmann A, Delmont JP, Knobloch J, Nielsen LN, Cuadros J, Hatz C, Beran J, Schmid ML, Schulze M, Lopez-Velez R, Fleischer K, Kapaun A, McWhinney P, Kern P, Atougia J, Fry G, da Cunha S, Boecken G, 2002. Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 34 :572–576.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Kimura M, Tomizawa I, Takizawa Y, Ohtomo H, 1996. A study of relapsed cases of vivax malaria after standard primaquine therapy. Kansenshogaku Zasshi 70 :1086–1091.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Jelinek T, Nothdurft HD, Von Sonnenburg F, Loscher T, 1995. Long-term efficacy of primaquine in the treatment of vivax malaria in nonimmune travelers. Am J Trop Med Hyg 52 :322–324.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK, Rieckmann KH, 1992. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 86 :121–122.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Hatz C, 2001. Clinical treatment of malaria in returned travelers. Schlagenhauf P, ed. Travelers’ Malaria. Hamilton: BC Decker Inc., 431–445.

    • PubMed
    • Export Citation
  • 15

    Kain KC, Harrington MA, Tennyson S, Keystone JS, 1998. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 27 :142–149.

    • PubMed
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 672 582 153
Full Text Views 251 9 2
PDF Downloads 59 8 2
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save